Hydroxylapatite (Ca5(OH)(PO4)3)

HCID 14781

Basic information

CAS
12167-74-7
Standard SMILES
O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[OH-]
InChIKey
XYJRXVWERLGGKC-UHFFFAOYSA-D
Molecular formula
Ca5HO13P3
Average molar mass
502.3 g/mol
Monoisotopic mass
501.675955

Names & identifiers

Preferred name
Hydroxylapatite (Ca5(OH)(PO4)3)
IUPAC
pentacalcium;hydroxide;triphosphate
English name
Calcium phosphate tribasic
Molecular formula
5Ca.3O4P.HO
Molecular weight
502.31

Names & synonyms

Durapatite1306-06-5Calcium hydroxyapatiteRadiesseMoniteWin 40350Apatite, hydroxyCalcium hydroxylapatiteSupertite 10Calcium phosphate hydroxideCalcium orthophosphate, basicHydroxylapatite (Ca5(OH)(PO4)3)
Show more names
CALCIUM ORTHOPHOSPHATETRI-CALCIUM PHOSPHATEpentacalcium hydroxide tris(orthophosphate)Si-HApALPHA-TCPIc acidtriEinecs 235-330-6TERT-CALCIUM PHOSPHATEHydroxyapatite, powderCELLULOSE HYDROXYAPATIT
Pentacalcium monohydroxyorthophosphateInterpore200Interpore500215-145-7235-330-6Interpore 200Interpore 500Hydroxyapatite, Calcium

Database identifiers

CAS
12167-74-7、1306-06-5
PubChem CID
14781
DTXSID
DTXSID50872537
ChEMBL
CHEMBL2218916
UNII
91D9GV0Z28
EC Number
215-145-7、235-330-6

Properties

Computed structural properties

Topological polar surface area
260 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
13
Rotatable bonds
0
Heavy atoms
21

Experimental & physicochemical properties

DensityDensity: 3.1 to 3.2 /Apatite/
Color/Form · 2 items

Hexagonal needles arranged in rosettes

Finely divided, crystalline, nonstoichiometric material.

SolubilityPractically insol in water, even when freshly prepared
Physical Description · 2 items

Dry Powder

Solid; [Merck Index] White suspension; [MSDSonline]

Other Experimental PropertiesDecomposes above 1100 °C

Physicochemical properties

Melting point
1100 °C · 1100 °C(lit.)
Density
1.038 g/mL · 1.038 g/mL at 25 °C
bulk density
2 · 2-6g/cm3
storage temp.
2 · 2-8°C
solubility
1 M · Soluble in 1 M Hydrochloric acid.
form
aqueous suspension

Safety & regulation

GHS classification

GHS Classification · 6 items

This chemical does not meet GHS hazard criteria for 97.8% (362 of 370) of all reports.

Not Classified;Reported as not meeting GHS hazard criteria by 362 of 370 companies (only 2.2% companies provided GHS information). For more detailed information, please visit ECHA C&L website.

Aggregated GHS information provided per 370 reports by companies from 5 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 362 of 370 reports by companies.;There are 3 notifications provided by 8 of 370 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

This chemical does not meet GHS hazard criteria for 94% (188 of 200) of all reports.

Not Classified;Reported as not meeting GHS hazard criteria by 188 of 200 companies (only 6% companies provided GHS information). For more detailed information, please visit ECHA C&L website.

Aggregated GHS information provided per 200 reports by companies from 6 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 188 of 200 reports by companies.;There are 3 notifications provided by 12 of 200 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Hazard information

Regulatory Information · 5 items

Chemical: Hydroxylapatite (Ca5(OH)(PO4)3)

Hydroxylapatite (Ca5(OH)(PO4)3) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Hydroxylapatite (Ca5(OH)(PO4)3) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Cease Manufacture Update: 15-08-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/20278

Status: Active Update: 19-01-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/15208

Hydroxylapatite (Ca5(OH)(PO4)3): Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Hydroxylapatite (Ca5(OH)(PO4)3): Environment tier I assessment;IMAP assessments - Hydroxylapatite (Ca5(OH)(PO4)3): Human health tier I assessment
Hazards SummaryMay cause irritation; [MSDSonline]
Hazard Classes and Categories · 2 items

Not Classified

Not Classified

Safety & protection

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Protective Action Criteria (PAC) · 3 items

190 [mg/m3]

2100 [mg/m3]

12000 [mg/m3]

Toxicology

Natural Pollution Sources · 2 items

A natural calcium phosphate (usually containing fluorine) occurring in earth's crust as phosphate rock. ... /Occurs in/ Eastern US, California, the former USSR, Canada, Europe. /Apatite/

The major constituent of bone & tooth material.

Human Toxicity ExcerptsDeposition of microcrystals such as ... calcium hydroxyapatite into joints can cause acute or chronic arthritis in a manner similar to that caused by monosodium urate deposition.
Populations at Special RiskCalcium hydroxyapatite deposition disease, or apatite gout, ... usually occurs in younger persons ...

Regulatory information

Regulatory Information · 5 items

Chemical: Hydroxylapatite (Ca5(OH)(PO4)3)

Hydroxylapatite (Ca5(OH)(PO4)3) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Hydroxylapatite (Ca5(OH)(PO4)3) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Cease Manufacture Update: 15-08-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/20278

Status: Active Update: 19-01-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/15208

Hydroxylapatite (Ca5(OH)(PO4)3): Does not have an individual approval but may be used under an appropriate group standard

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
tsca
Yes
hs_code
2835260000
risk_code
36/37/38
Signal word
Warning

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

CALCAREA PHOSPHORICA

Cations, Divalent [CS]; Phosphate Chelating Activity [MoA]; Calcium [CS]; Blood Coagulation Factor [EPC]; Phosphate Binder [EPC]; Increased Coagulation Factor Activity [PE]

MeSH Pharmacological ClassificationSynthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.

Uses & manufacturing

Uses · 6 items

Naturally occurring mineral in phosphate rocks and in bone; [Merck Index] Used in fertilizers, laser crystals, ion-exchange chromatography (especially for proteins), artificial bone and teeth, and calcium/phosphorus supplement; [HSDB]

Source of phosphorus & phosphoric acid; mfr of fertilizers; laser crystals /Apatite/

USED IN DENTURE & ORTHOPEDIC MATERIALS; USED IN ION-EXCHANGE CHROMATOGRAPHY ESPECIALLY FOR PROTEINS

MEDICATION

Prosthetic aid (artificial bone and teeth).

For more Uses (Complete) data for HYDROXYAPATITE (6 total), please visit the HSDB record page.

U.S. Production2023: 10,000,000 - <50,000,000 lb;2022: 10,000,000 - <50,000,000 lb;2021: 10,000,000 - <50,000,000 lb;2020: 10,000,000 - <50,000,000 lb
Consumer UsesNot Known or Reasonably Ascertainable;Filler
Industry UsesProcessing aids not otherwise specified;Filler;Soil amendments (fertilizers);Stabilizing agent
Methods of Manufacturing · 2 items

Prepd from Ca(NO3)2 and KH2PO4; from calcium phosphate, dibasic; from Ca(NO3)2.4H2O and (NH4)3PO4 plus NH4OH.

Dense hydroxyapatite ceramics are made by compressing calcium phosphate solids from a very fine powder form, known as greenstate, into a pellet which is then subjected to a heat treatment that causes the powder particles to fuse together by means of solid-state diffusion.

Household ProductsInformation on 13 consumer products that contain Calcium phosphate hydroxide in the following categories is provided:;• Landscaping/Yard
Applications · 3 items

UsesCalcium phosphate tribasic (C3161) is plant cell culture tested (0.2 mg/ml) and is appropriate for use in plant cell culture experiments. Calcium phosphate tribasic is utilized to engineer new biomaterials for applications such as bone grafts and fillers.

UsesSi-substituted hydroxyapatite (Si-HAp) nanopowder can be incorporated in biodegradable polymer composites or deposited on biocompatible surfaces similar to pure HAp nanopowder (cat. no. 677418). Biological activity of HAp was shown to be enhanced by substitution of silicon ions into a fraction of HAp lattice phosphate sites.1,2

General DescriptionHydroxyapatite is a key inorganic phosphate that has chemical and structural resemblance to bone. HAp is a popular biomaterial which finds use as a bone or teeth replacement and repair, hard tissue repair.

Upstream & downstream products

Upstream raw materials

Suppliers100 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
郑州阿尔法化工有限公司+86-18530059196 · [email protected]
湖北永阔科技有限公司027-59223108 15972152991 · [email protected]
湖南韵邦生物科技股份有限公司85561037 15386497078 · [email protected]
湖北万得化工有限公司15377098680 15377098680 · [email protected]

Related reactions

10 records

Compound notes

Loading…